House committee probes FTC disclosure of confidential info in reviewing Amgen-Horizon deal

Zachary Brennan

Senior Editor

House Oversight Committee Chair James Comer (R-KY) sent a stern letter to FTC chair Lina Khan last week, claiming the commission improperly disclosed confidential information …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

House committee probes FTC disclosure of confidential info in reviewing Amgen-Horizon deal

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA approves first drug to treat ultra-rare lipid storage disease

Will CRISPR matter?

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

House com­mit­tee probes FTC dis­clo­sure of con­fi­den­tial in­fo in re­view­ing Am­gen-Hori­zon deal

Senior Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

House committee probes FTC disclosure of confidential info in reviewing Amgen-Horizon deal